<SEC-DOCUMENT>0001558370-24-008845.txt : 20240603
<SEC-HEADER>0001558370-24-008845.hdr.sgml : 20240603
<ACCEPTANCE-DATETIME>20240603071851
ACCESSION NUMBER:		0001558370-24-008845
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240603
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240603
DATE AS OF CHANGE:		20240603

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			uniQure N.V.
		CENTRAL INDEX KEY:			0001590560
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36294
		FILM NUMBER:		241011979

	BUSINESS ADDRESS:	
		STREET 1:		PAASHEUVELWEG 25A
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1105 BP
		BUSINESS PHONE:		1-339-970-7000

	MAIL ADDRESS:	
		STREET 1:		PAASHEUVELWEG 25A
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1105 BP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	uniQure B.V.
		DATE OF NAME CHANGE:	20131030
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>qure-20240603x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.6.2.5 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 6/3/2024 7:53:08 AM -->
<!-- iXBRL Library version: 1.0.8826.24652 -->
<!-- iXBRL Service Job ID: 3c1aeb65-e14f-45d0-8fc8-4fc276880654 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:qure="http://www.uniqure.com/20240603" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityTaxIdentificationNumber" id="Hidden_YkCjrdxncU2dd2-9nog91A">00-0000000</ix:nonNumeric><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityCentralIndexKey" id="Tc_dJHS-MCsAU-wGB5Fmk37DA_3_1">0001590560</ix:nonNumeric><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:AmendmentFlag" id="Tc_21EXZaubJkuYwE4eMwpt8A_4_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="qure-20240603.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001590560</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-03</xbrli:startDate><xbrli:endDate>2024-06-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_d1a947e6_f135_4660_82b9_b03b9fa8e20f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">WASHINGTON, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:18pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:DocumentType" id="Narr_md5reVqNQEGlN7zyH3gz3A"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_hEcUCgAnm0myVwWGIrSjQA"><b style="font-weight:bold;">June 3, 2024</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:16pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityRegistrantName" id="Narr_Qd9mlma1eUOra0pUfFwcCw"><b style="font-weight:bold;">uniQure N.V.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;">(Exact Name of Registrant as Specified in Charter)</p><a id="_018468e3_9bf6_444a_a3a0_db8be314b337"></a><a id="Tc_RGtun1XE1E-mfSIjNV-Gzw_1_0"></a><a id="Tc_dm0CS0QnwkmBe3KgJTiq6g_2_0"></a><a id="Tc_u19pCMHhIUOpj1TGJgmlTQ_2_2"></a><a id="Tc_xek2lxpLv0u7-iwhhGWAtg_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:34.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:25.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:34.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:34.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">The </b><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="Narr_6B5MhsO92ES1IslqrsQjOQ"><b style="font-weight:bold;">Netherlands</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:25.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityFileNumber" id="Tc_OpsnB6cyZEiZSj07UU6M7w_1_2"><b style="font-weight:bold;">001-36294</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:34.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_YkCjrdxncU2dd2-9nog91A;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">N/A</b></span></p></td></tr><tr><td style="vertical-align:top;width:34.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(State or Other<br/>Jurisdiction of Incorporation)</p></td><td style="vertical-align:bottom;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:25.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Commission<br/>File Number)</p></td><td style="vertical-align:bottom;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:34.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(IRS Employer<br/>Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:63.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:34.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:63.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityAddressAddressLine1" id="Narr_bPf8SnuMEkmPPbFNjqFTFQ"><b style="font-weight:bold;">Paasheuvelweg 25a</b></ix:nonNumeric><b style="font-weight:bold;">,</b><br/><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityAddressPostalZipCode" id="Narr_ZQi4-KZdKk-jLyHqyrZw_A"><b style="font-weight:bold;">1105 BP</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:EntityAddressCityOrTown" id="Narr_8GsNLhI2qkur-2K_klUfAw"><b style="font-weight:bold;">Amsterdam</b></ix:nonNumeric><b style="font-weight:bold;">, The </b><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="Narr_zIm7XHBd_0OCjvu7uBNklw"><b style="font-weight:bold;">Netherlands</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:34.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p></td></tr><tr><td style="vertical-align:top;width:63.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Address of Principal Executive Offices)</p></td><td style="vertical-align:bottom;width:2.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:34.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 14pt 0pt;">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:CityAreaCode" id="Narr_yXn-4FiQTk-1wo9EZiK_Dw"><b style="font-weight:bold;">+31</b></ix:nonNumeric><b style="font-weight:bold;">-</b><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:LocalPhoneNumber" id="Narr_zsQIVp5ViEi09XeQ1EK0Kg"><b style="font-weight:bold;">20-566-7394</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;">(Former Name or Former Address, if Changed Since Last Report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 8pt 0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i style="font-style:italic;">see</i> General Instruction A.2. below):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_Wprl41icdUetLrXXGgi3Kg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_xjMZQM6QX0Cujji0gui8GA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_JXlAwxFmkUiYC7pg5sqN0w"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_O5KB_10IU06Dth0vWWcdzA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><a id="_3bb4dd6b_4cae_4d1e_971d_4c350a20d0cb"></a><a id="Tc_DiYGG1bylkqAah1e59nZsw_1_0"></a><a id="Tc_ZzRXNv2Bb0iHO3h2hOq1Jw_1_2"></a><a id="Tc_xLKoIJsr-kuFm63VLvYgNQ_1_4"></a><a id="Tc_YSfM8I3IIEKn4b6v6GpTIw_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:37.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:41.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:37.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title&#160;of&#160;each&#160;class:</b></p></td><td style="vertical-align:top;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.8%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:41.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which registered:</b></p></td></tr><tr style="height:1.7pt;"><td style="vertical-align:top;width:37.18%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:Security12bTitle" id="Tc_HVmhjzFxKkeg0AkqvbNF9A_2_0">Ordinary Shares, par value &#8364;0.05 per share</ix:nonNumeric></p></td><td style="vertical-align:top;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:17.53%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" name="dei:TradingSymbol" id="Tc_q5_p0WlZZUS-gQ3wY1CL0A_2_2">QURE</ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:41.16%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Narr_ojse6a-Lc0-9AuVJUj1wvg">The Nasdaq Stock Market LLC</ix:nonNumeric><br/>The Nasdaq Global Select Market</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_8ZqHfpCvZEa9Gug2FtSUXA"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_5aaf5511_5c55_4fec_9eb5_bf8e1a451e48"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 7.01</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b style="font-weight:bold;">Regulation FD Disclosure.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">On June 3, 2024, uniQure N.V. (the &#8220;<span style="font-style:italic;font-weight:bold;">Company</span>&#8221;) issued a press release announcing that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its investigational gene therapy candidate AMT-130 for the treatment of Huntington&#8217;s disease. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The information provided in this Item 7.01, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="font-style:italic;font-weight:bold;">Exchange Act</span>&#8221;), or otherwise subject to the liability of such section, nor shall it be incorporated by reference in any filing made by the Company pursuant to the Securities Act of 1933, as amended (the &#8220;<span style="font-style:italic;font-weight:bold;">Securities Act</span>&#8221;), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</p><a id="_a985340f_59ba_4ad6_a0a8_4068336e0095"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item 9.01</b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b style="font-weight:bold;">Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:12.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Exhibit&#160;No.</p></td><td style="vertical-align:top;width:2.01%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:85.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Description</p></td></tr><tr><td style="vertical-align:top;width:12.62%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:85.35%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="qure-20240603xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release of uniQure N.V. dated June 3, 2024</span></a></p></td></tr><tr><td style="vertical-align:top;width:12.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:top;width:2.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:85.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page&#160;Interactive Data File (embedded with the Inline XBRL document).</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_56d30076_bcbb_4eb8_9047_4013f24f0853"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:3.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:43.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="2" style="vertical-align:top;width:47.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">UNIQURE N.V.</b></p></td></tr><tr><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:top;width:47.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: June 3, 2024</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:top;width:43.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Jeannette Potts</p></td></tr><tr><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.43%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">JEANNETTE POTTS</p></td></tr><tr><td style="vertical-align:top;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Legal and Compliance Officer </p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>qure-20240603xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 6/3/2024 07:53:07 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial Narrow';font-size:10pt;text-align:right;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:right;margin:0pt;"><img src="qure-20240603xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:36.28pt;width:123.8pt;"></p><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial Narrow';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) </b><b style="font-size:12pt;font-weight:bold;"><br></b><b style="font-size:12pt;font-weight:bold;">Designation for Investigational Gene Therapy AMT-130 in Huntington&#8217;s Disease</b></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:12pt;font-style:italic;">~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~</i></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:12pt;font-style:italic;">~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington&#8217;s disease ~</i></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><i style="font-size:12pt;font-style:italic;">~ Receiving RMAT designation enables increased collaboration with the FDA on regulatory approval planning, in addition to the opportunity for expedited product development ~</i></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Lexington, MA and Amsterdam, the Netherlands,</b><font style="font-size:12pt;"> June 3, 2024 &#8212; uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its investigational gene therapy AMT-130 for the treatment of Huntington&#8217;s disease.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The FDA granted RMAT designation based on the potential of AMT-130 to address the major unmet medical need among patients with Huntington&#8217;s disease. The designation follows the FDA&#8217;s review of interim Phase I/II clinical data for AMT-130 announced in December 2023 and is based on an analysis comparing these 24-month clinical data to a non-concurrent criteria-matched natural history cohort.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">&#8220;We&#8217;re thrilled to receive the first ever RMAT designation for an investigational therapy for Huntington&#8217;s disease,&#8221; stated Matt Kapusta, chief executive officer of uniQure. &#8220;This achievement is a significant milestone for the program and supports the potential for AMT-130 to address the high unmet medical need of those suffering from this devastating disease.&#8221;</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">&#8220;The RMAT designation, which was based on the comparison of the two-year AMT-130 data to a natural history cohort, marks a promising start to our FDA interactions,&#8221; stated Walid Abi-Saab, chief medical officer of uniQure. &#8220;Importantly, RMAT designation allows for increased collaboration with the FDA to accelerate development, potentially facilitating earlier access for patients with life-threatening medical conditions. I&#8217;m incredibly proud of the team at uniQure for this accomplishment, and we look forward to presenting updated interim data from our ongoing Phase I/II studies in the middle of the year.&#8221;</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">RMAT designation was created as part of the 21</font><sup style="font-size:9pt;vertical-align:top;">st</sup><font style="font-size:12pt;"> Century Cures Act to expedite the development and review processes of regenerative medicine therapies. A regenerative medicine therapy can be eligible for RMAT designation if it is intended to treat, modify, reverse or cure a serious condition, and if preliminary clinical evidence indicates that the drug has the potential to address unmet medical needs for such a condition. Receiving RMAT designation offers sponsor companies all the benefits of the fast track and breakthrough therapy designation programs, allowing for early, close and frequent interactions with the FDA. This includes opportunities for early agency interactions to discuss the use of surrogate or intermediate endpoints, potential approval pathways including ways to support accelerated approval, and other opportunities to expedite development.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">uniQure expects to provide updated interim data from the ongoing Phase I/II U.S. and European studies of AMT-130 in the middle of 2024. The interim update will include up to three years of follow-up on 29 treated patients, 21 of which will have been followed for at least two years.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">About the Phase I/II Clinical Program of AMT-130</b></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The&#160;U.S.&#160;Phase I/II clinical trial of AMT-130 for the treatment of Huntington&#8217;s disease is exploring the safety, tolerability, and efficacy signals in 26 patients with early manifest Huntington&#8217;s disease split into a 10-patient low-dose cohort followed by a 16-patient high-dose cohort. Patients are randomized to treatment with AMT-130 or an imitation (sham) surgery. The multi-center trial consists of a blinded 12-month core study period followed by unblinded long-term follow-up for a period of up five years. A total of 16 patients in the clinical trial were randomized to treatment and received a single administration of AMT-130 through MRI-guided, convection-enhanced stereotactic neurosurgical delivery directly into the striatum (caudate and putamen). An additional four control patients in the high-dose cohort crossed over to treatment following the core study period. Additional details are available on&#160;www.clinicaltrials.gov&#160;(NCT04120493).</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">The European, open-label Phase Ib/II study of AMT-130 enrolled 13 patients with early manifest Huntington&#8217;s disease across two dose cohorts; a low-dose cohort of six patients and a high-dose cohort of seven patients. Together with the&#160;U.S.&#160;study, the European study is intended to establish safety, proof of concept, and the optimal dose of AMT-130 to take forward into Phase III development or into a confirmatory study should an accelerated registration pathway be feasible.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Patient dosing is ongoing in a third cohort of up to 12 patients to further evaluate both doses of AMT-130 in combination with perioperative immunosuppression. Enrollment in this third cohort is expected to be completed in the second half of 2024. AMT-130 is uniQure&#8217;s first clinical program focusing on the central nervous system incorporating its proprietary miQURE</font><sup style="font-size:9pt;vertical-align:top;">&#174;</sup><font style="font-size:12pt;">&#160;platform.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">About Huntington&#8217;s Disease</b></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">Huntington&#8217;s disease is a rare, inherited neurodegenerative disorder that leads to motor symptoms including chorea, behavioral abnormalities and cognitive decline resulting in progressive physical and mental deterioration. The disease is an autosomal dominant condition with a disease-causing CAG repeat expansion in the first exon of the huntingtin gene that leads to the production and aggregation of abnormal protein in the brain. Despite the clear etiology of Huntington&#8217;s disease, there are currently no approved therapies to delay the onset or to slow the disease&#8217;s progression.</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">About uniQure</b></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">uniQure&#8217;s mission is to reimagine the future of medicine by delivering innovative cures that transform lives. &#160;The recent approvals of our gene therapy for hemophilia B &#8211; a historic achievement based on more than a decade of research and clinical development &#8211; represent a major milestone in the field of genomic medicine and ushers in a new treatment approach for patients living with hemophilia. We are now leveraging our modular and validated technology and manufacturing platform to advance a pipeline of proprietary gene therapies for the treatment of patients with Huntington&#39;s disease, refractory mesial temporal lobe epilepsy, amyotrophic lateral sclerosis (ALS), Fabry disease, and other severe diseases.&#160;www.uniQure.com</font></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">uniQure Forward-Looking Statements</b></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-size:12pt;font-style:italic;">This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as &quot;anticipate,&quot; &quot;believe,&quot; &quot;could,&quot; &#8220;establish,&#8221; &quot;estimate,&quot; &quot;expect,&quot; &quot;goal,&quot; &quot;intend,&quot; &quot;look forward to&quot;, &quot;may,&quot; &quot;plan,&quot; &quot;potential,&quot; &quot;predict,&quot; &quot;project,&quot;</i></p><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><i style="font-size:12pt;font-style:italic;">&#8220;seek,&#8221; &quot;should,&quot; &quot;will,&quot; &quot;would&quot; and similar expressions. Forward-looking statements are based on management&#39;s beliefs and assumptions and on information available to management only as of the date of this press release. Examples of these forward-looking statements include, but are not limited to, statements concerning the potential of AMT-130 to address the unmet medical needs of Huntington&#8217;s disease patients; the potential that RMAT designation will expedite the ongoing development of AMT-130 and facilitate earlier access to Huntington&#8217;s disease patients; the Company&#8217;s plans to present updated interim data from the ongoing Phase I/II U.S. and European studies of AMT-130 in mid-2024; and the Company&#8217;s plans regarding the third cohort in its AMT-130 clinical trial and the timing of enrollment for such cohort. The Company&#8217;s actual results could differ materially from those anticipated in these forward-looking statements for many reasons. These risks and uncertainties include, among others: risks associated with the Company&#8217;s clinical results and the development and timing of its programs; the Company&#8217;s interactions with regulatory authorities, which may affect the initiation, timing and progress of clinical trials and pathways to regulatory approval; whether RMAT designation or any accelerated pathway will lead to regulatory approval; the Company&#8217;s ability to conduct and fund a Phase III or confirmatory study for AMT-130; the Company&#8217;s ability to continue to build and maintain the company infrastructure and personnel needed to achieve its goals; the Company&#8217;s effectiveness in managing current and future clinical trials and regulatory processes; the continued development and acceptance of gene therapies; the Company&#8217;s ability to demonstrate the therapeutic benefits of its gene therapy candidates in clinical trials; the Company&#8217;s ability to obtain, maintain and protect its intellectual property; and the Company&#8217;s ability to fund its operations and to raise additional capital as needed. These risks and uncertainties are more fully described under the heading &quot;Risk Factors&quot; in the Company&#8217;s periodic filings with the U.S. Securities &amp; Exchange Commission (&#8220;SEC&#8221;), including its Annual Report on Form 10-K filed February 28, 2024 and in other filings that the Company makes with the SEC from time to time. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements, even if new information becomes available in the future.</i></p><p style="font-family:'Arial Narrow';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">uniQure Contacts:</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:44.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">FOR INVESTORS:</b></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:31.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:19.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">FOR MEDIA:</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:31.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:19.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:44.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Maria E. Cantor</b></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:31.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Chiara Russo</b></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:19.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Tom Malone</b></p></td></tr><tr><td style="vertical-align:bottom;width:44.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Direct: 339-970-7536</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:31.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Direct: 617-306-9137</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:19.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Direct: 339-970-7558</font></p></td></tr><tr><td style="vertical-align:bottom;width:44.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Mobile: 617-680-9452</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:31.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Mobile: 617-306-9137 </font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:19.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Mobile:339-223-8541</font></p></td></tr><tr><td style="vertical-align:bottom;width:44.61%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">m.cantor@uniQure.com</font><font style="display:inline-block;width:3.39pt;"></font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:31.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">c.russo@uniQure.com</font></p></td><td style="vertical-align:top;width:2.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:19.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">t.malone@uniQure.com</font></p></td></tr></table></div><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial Narrow';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>qure-20240603xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 qure-20240603xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !$ .@# 2(  A$! Q$!_\0
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M4HF*1D\"5!NR/JN1^ KZQUK7;+P[I4^H:C<):V4 #23/T49Q_6OU'(LXCFV
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M7_BY7AKWU"'_ -"%?H+M&VOS\^%O_)2?#)_ZB$/_ *$*_03/%?FWA[_NE?\
MQ+\C]+\1?]]H_P"#]3X"^,"_\70\3_\ 7Z_]*^P_@8O_ !:;PS_UYK_,U\>?
M%\_\71\3_P#7Z_\ 2OL7X%_\DF\,_P#7HO\ ,UP<(?\ ([QOS_\ 2COXP7_"
M'@?E_P"DGRQ^TJ/^+OZOCILA_P#18KFO!GP\\3_$G,6D6LEW!:?(9)9 L46<
MG:"?7.<#UKIOVE 6^+NK_P"Y#_Z+%>__ ++=K''\*+9XT57DN9B[#JQW8Y_
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M>M>SP1A\32QN)GB8.+:ZKK?4\;CC$X6M@<+#"U%))]'TLK'QG\<O^2M>)O\
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%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>qure-20240603.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/3/2024 7:53:13 AM-->
<!--Modified on: 6/3/2024 7:53:13 AM-->
<xsd:schema targetNamespace="http://www.uniqure.com/20240603" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt="http://fasb.org/srt/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt-roles="http://fasb.org/srt-roles/2023" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:rxp="http://xbrl.sec.gov/rxp/2023" xmlns:snj="http://xbrl.sec.gov/snj/2023" xmlns:shr-10b51="http://xbrl.sec.gov/shr-10b51/2023" xmlns:shr-exh="http://xbrl.sec.gov/shr-exh/2023" xmlns:shr-narr="http://xbrl.sec.gov/shr-narr/2023" xmlns:shr="http://xbrl.sec.gov/shr/2023" xmlns:qure="http://www.uniqure.com/20240603">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.uniqure.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="qure-20240603_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="qure-20240603_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>qure-20240603_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/3/2024 7:53:13 AM-->
<!--Modified on: 6/3/2024 7:53:13 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Country</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>qure-20240603_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 6/3/2024 7:53:13 AM-->
<!--Modified on: 6/3/2024 7:53:13 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="qure-20240603.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.uniqure.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.uniqure.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638529979937290403" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638529979937290403" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638529979937300415" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638529979937300415" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638529979937300415" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638529979937300415" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638529979937300415" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638529979937300415" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638529979937300415" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638529979937300415" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638529979937300415" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638529979937300415" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638529979937300415" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638529979937300415" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638529979937310390" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638529979937310390" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638529979937310390" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638529979937310390" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638529979937310390" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCountry_638529979937310390" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638529979937310390" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638529979937310390" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638529979937310390" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638529979937320391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638529979937320391" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638529979937320391" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638529979937320391" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140477136864608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 03, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  03,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">uniQure N.V.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">P7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Paasheuvelweg 25a<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Amsterdam<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">1105 BP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">20-566-7394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, par value &#8364;0.05 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">QURE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001590560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">NL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( %DZPU@'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ 63K#6"F 3!7O    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ 63K#6)E<G",0!@  G"<  !,
M     ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !9.L-8
M4G]TUTP$  "K$   &               @($."   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ 63K#6)^@&_"Q @  X@P   T
M     ( !D P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !9.L-8EXJ[',
M   3 @  "P              @ %L#P  7W)E;',O+G)E;'-02P$"% ,4
M" !9.L-8'#AEZC\!   \ @  #P              @ %5$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ 63K#6"0>FZ*M    ^ $  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M63K#6&60>9(9 0  SP,  !,              ( !IA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  \!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="qure-20240603x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.uniqure.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>qure-20240603.xsd</File>
    <File>qure-20240603_lab.xml</File>
    <File>qure-20240603_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="qure-20240603x8k.htm">qure-20240603x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "qure-20240603x8k.htm": {
   "nsprefix": "qure",
   "nsuri": "http://www.uniqure.com/20240603",
   "dts": {
    "schema": {
     "local": [
      "qure-20240603.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "qure-20240603_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "qure-20240603_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "qure-20240603x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qure-20240603x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qure-20240603x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.uniqure.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001558370-24-008845-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-24-008845-xbrl.zip
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MG7?7WW]W^8/C?+[Y-(&0!NL8$0X!0SY'(6PP7\*4KE8^@3O$&(XBN&$X7"
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M&Y3[-&6E]84+9C4/GC;>$M,%5!3,9;!F*%^;N3+@*A7S4PA\(2;('YRMD^6
MA1&FV\HM32FZ&7:<FX!RY2JE\4!DR'$PI#YL_H1J/PYP37*B#G7EP85KX'X(
MU)<'O!\"O"C1OM#>#,U/4U9:7[7 S4ZK3E:W&:P9RM=FK@PX+FQ%*G/@'/Q1
M)D@EU91GJIKL1)A\_*0_ /U4"[^(81*@8C$-5S0_UXI+/"S%-</$^M25B\?%
M\(V[.&$!\4@BGHUCG  GN&P#? QJAG\U>:N?ZXX+[!LW[YF#G)M /4A_$I9O
M$/!/\WEIL5X-+HIB"U&L&S3S3/[*U.,"OEFF#N-X!?PL:X^Z--+@>EDHFX^/
M#'Z4S0_&X6M \K4Q(_. 9*_2O/T74$L#!!0    ( %DZPUAP4I31A10  'Z'
M   4    <75R92TR,#(T,#8P,W@X:RYH=&WM/6M7XCK7W]]?D=>SGC/.>FWI
MC:N.ST)$Q0M>P!G'+ZRT#1 I+:8ME_GU[T[:8D$4]7C!.3-KC= V3?;>V??L
MA*W_COL.&A+F4\_]]D65E2^(N)9G4[?S[4NY4:G5OOQW^W^V_E>2$+W:N3A&
MMF>%?>(&R&($!\1&(QIT2ZCI#0;812>$,>HX:(=1NT/B5U1%SLF:G$62%'>U
M@WUXTW-+20M9O7M8B3OFCW,9/:,IFH'RI:Q>4@JH?'+7,'KWF)H,LTF"1 DZ
M4^1"08,AC5Q6FV_>(&Q(+8(./1/5=DM(MU1,S%Q6(JK1EHRLK4B%ME60C+:E
MY7.%@I++&E$?W0!(!>1R_9)-Z+>U;A ,2IG,V&2.[!-+[GC###S@\.IK4<-I
MH]%H)(]TV6.=C%HL%C-CWEG<J'0;,C+3,G0IOR=;7E]@K^24I,>20]W>3&,Q
M/N]84Q0]PQ^;0-VD^?A>^QDP^--I4^C(#F;QBOO-9J*'TZ8+,8.&:N;JY+AA
M=4D?2]3U ^Q:4U#H.)" 3C-O)G2C+D!"^ 1E H9=O^VQ/@Y@.J%3-2LI!4E7
M4_TL)L"R3C1)R]UU\A 153W54=*<D?:#1,]EX&F:B/21^9D297NK2["]O=4G
M 4:\N41N0SK\MF9Y;@#R)063 9 NOOJV%I!QD!%<D]G>"FC@D.VM3/(9=65Z
M]F1[RZ9#Y <3!UBJCUF'NE+@#4JZ,@@V8= ,/)YI8U-_X.!)R?5<PAO0<8GW
M1ECTE=HV<<57:% 'R6?4BH :!Q><*+LA$S1NY5IZBS-KJ^G=??\^85>G93N8
M]'+'ZNCX6J^4+Z[*:\C%?3XVH:6J"TA,FGA<@X$"VJ:6Z Z&,@E;0]3^MG8@
M@&C][%5NF#UVK4O-MC6IZ'J=HEI>VU8428G^;65FX'Q[L"L ,L-.S;7)^(A,
M(G";5LL^/&A()Q6_?"F-]G>R>_V>GM\M0^\J!Q>8L:AD<^\);AE4MLW5]IZ#
M.U,P-;5Z=8U#\[ 7_AQ5#7(R&@2%<LO@8+:QXY-[$&9F>0(8GS"P%\3?WN*J
MI.0+T0>0D5 MI:X0'*[,I$21R6/?7HL?<Q[_MN;3_L AG*\S<WV*2]\+F;@2
MLE6*R2)P>!%9DHZ(F,+DBL;L1Q@22)"%>JI2.YJ=P?F7MY-;L[T/@'R>G5R!
M"F#!+ABY;0ZGI.0D14_>NWLV!=-^H&GR)+E.!LG,$"JAZI2,F92(WU,'?3R6
M1M0&DZXJRG\V!]CFKH#DD'8 =V0]>W>/T4[W[J;G4SX3,) #4S(4NB35K^40
MS$JF%W0WYX=8].8@>:\-2$AMW*?.I/2E2?O$1W4R0A=>'[M?-J([\.D#ZNTO
MFZ*U3W\1Z!KT7:3_2K'J\[F#DNXV:@@/A]2G)G5@OF+FAN9__U70%'US*\-?
M T(-7@NHA'Q B\#KB_&36UQ1\VL^;1)V:,<M6<!'A&V:'H/YFKXC0T?(]QQJ
MH[\BU9>T$+I^P>.5),5]/)\"9O;I8&*A)5JVBHM&GN1:;57/MHQ<3FD5-+/8
M,A7=++9Q@6A*F]M&_%Z(F0N(7X!'XG)$A&"9GF-#V\MZK5G=18UFN5EM;&7,
M]Z3_,\!L5"N7%[5FK=I Y?HNJEY5#LKU_2JJG)Z<U!J-VFG]'6%'_'\A^KR/
MQRS@/\J-@UI]OWE:WT"[<D5&FI(UBJ\(;.$5@=T[O3CY^R\UIVP* -_.7]B-
MH[RF<$*Y$-4Q8ZV^G67D^VW]O+KOU/._)@=ZYY=>7@)T03J*R#GO2ZP +T1]
M:(MY&CCZHEIOHHOJV>E%<T7Y]RQD?H@A'@\\B&TM/ND1AZ@Z\AA2L^OVU^B&
MUT9!E_!&(0.+"]!6QU87NQ"GEZT P6.UJ!L?AR;W93@4%V3@L0"M)]?@.#@
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M6H".3WA-_3;:)RYA8)%J+O0>1GG2LJS)$59?2Z](ZX?+RM[:P30]SS$Q$"F
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M7M"XO'K=%/J_B@]J[4<$F1?/+-0*]-ZB?Q=D7NA7D'G7$TGVT">B%?!/7%K
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M?2KYR"]786H5T<BCMVV(Q X9;KI2]*+=0:W#1 PG())KR6OIG/BG+,&:[*"
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M)UTA&AA:U4)KZ^I4<S+H0PDJU4Q%PLA2]L\3MFR![#XVR_!C2=89.!@-(]W
MDNT=3[ A\-.1T@)USI0XP[JS/MYX5U9W ;'7\)4+J,V*\X2](J:[3$ [TR7U
MA= )_9--X2406K53ICRF3$T>UQ/G.Y<LJ9(14R44&(!U>0/:DI)&M&8$)MLH
M4A]/.'V"CYL4&ND0=:J":>#]A"P18 TS,K5=6;2W0FP&J\LTDD%)6!$C,;A+
M%4(\#B%/<,JNLLF4\D=*%=?1O(7@V\#MO<[60#>YHJ&WJ[PQ!/!6V!+>1WQP
MODPF#@?GHZ>0Y(P2S6 C,TF%(?#K#;,VA4C>P*E-/5\T$FX?$"(4$F<&(8XE
M5.4 +2#")*,P0QO-*O5SS5&O!8]KJ$09%RLDR>J4;*$IG&+ZSIL*">4GR_5]
M(#;$JJ0.@:^V[+46B8^9$\0Q,&(]29-^A\I+.+^S+<!KU7/2+>[D,M)"//&O
M."4$X19\ILU[WA@,26F#^+8?M'Q@CS*MB+9$9N*L!U)#]KL#1;F\W491+I1(
M%%=U94H%=XRXVLK:MR"6:D&?=,>#_,&P$9AJL H\\W5UI3P@\YX^,^_B,VKI
MG'@_I@([Q"<4FD-:%Q(#VF\A;\GV54SKL9JS1$=U)GG G?'[?ZB.?IU"/DJ[
ME!OU^-F9_"/UZC]2?]?_N:CBRU.@S1P04Z0H5S)3G7XVX'\F+7;6/PC]:Q(5
M=[7#[X/[N Z/6G./\*0]]M@<:Y1 F2Z#7U?.8(ZG,B,(""(\/NZ-#C^?(+E*
M516:TH.M0<F?8OSR)V_9?]P^U_G4U#X\M^#L(H;S[T(QMD*QC]3J_@A-E"\^
M&QX-)H2\_J?[6A"NVNB</+!M1.D2X@/\,+0?A)4SY9;4,Z-8Z(W%1T%%I8Q$
MF.9,(>.4>G2T43'X>)XC(9FA[MUULD7>SZD#U6;#03?L(PCV4THQ?'VV O/I
MDA8>-0NI%&ZO[(GO(BD28:\"S2CH_MW* UD>3&845^@BY%P14;O/+F3^F+*,
MN:J6/G;E=>9TU_>O@\"1J%E4D1RII)A"&Y1N#D>Q;V-P/@5(U$&47J9K3-1%
M?"%#I.U2"M,*=QRRXFM4->(1Y<0^<@DJ])Q7^; E^Q!Z-^SB3NV0@T_6N=N2
M<M.BF"-JR_7V9[LG%S+&ZU<ONO,:643:(3G<*L[7NBK.^*F)K$!C0B.(0B%?
M(&GZ-A82:N3?R#8U3D;=Z]7/9D<4NSH7CQ)9<XY ])6UDR#V,?A>=>&Y05)3
MXENXRF1;0MBT"Y1.QG+3@#I):S+P8H^FOZ4V'+LZ,U5.ZLS;EKS%CS1D$&38
MY)QT32!*GX5O>W-SZS][]/+B9G X' T.3\:/]RA!)...^5P'Z:U"1)53E46D
MG,;Z>=FV U5 Z-2M&XY_M>]+5@EG9"U%V0G-!#;<GW)^_79U$IF%W-8Q+4,6
M7C0+X;MFSB.,IB+9!%1FS0\[UM+:Y681"6Z@;&T7#3HBD<:)^)=ZL:H,K0L_
M&W(Z)W,QOF!I]?&<?*.:M@9;?A TQ-PNHWUE8WQ!.-,T]Z!^E2?-+DR=I=P_
M;M4K*)]73AMJ':J89Q W5<Q[9'4!I$E Y'@0=:PW:-)&?:$J;6G55P?#T<H"
M\.NLKEBS"B5:36!!J0F+?+,@074\U46K7\:>7<9.@\[SNC!4 5)]SI7W%=NW
M[^86ODVU1I./F( O;QM3WX7,E*^G/)@IJN11D&2S51G4&M>&RJQQ"]_H;L [
M=HAG!M4O"29V.T%3Q7V#ZI9:%G8)K.6NFZE*;@J2$"$A;%!6&G@%J\DUC=M^
M79,(;O+T</(^C2+O4"520)K3_;[6]N!D\#>_Y_"A+K([7Y,(Z96BP31<@*?.
M'&73=@<-R[F0\<TIFK.RW^3&4;=IF9<HI=J]D 2FK60'UHPJ6ANR,CDM:.2:
M^78'P5MBYM3\H.T5&2MR"V4I.?*^RV9+7H0%Y6)IV9;I/?(E'T#)]SQ(A5E<
MBRLX?^V,-1X\J>]&\ZW8$?/.*^,;760)[!H7YU^#"D"W(Z^D2WS4"2S:\Z.W
MJ^G (@@6"\+0M2V=,)VA 3YWX"G2S,'2O,F%HDQHF5.Z.6E:20V6+I4M8U^4
M2R:A\&9FYLO=63C'($HK\%^8["&0%B:TH7AB'6?>U!9#J;4,G1JK.%Y0&PN1
MT[<A_:;-(8U>(/7]=LR BWOBA9LHG6OKK<OZ027"_#PTJ1&0'+7:S&S5NYXN
M8[[K_:,PM]XW$^ZE^ZYQO-D@:*&ET1#A*+D&I>:4I8=&),<URGK7+@M0L;!0
MN2D7J-.D^,I?O!A..$.B*1=2\/9XLAF>Y8;GKN1TY,PR5;Y/#\NIJ!5-WMX,
MGUNI2=P?+N=G,GC?3^=7@\[&^U3&%0PHACLG*\G0[K5=4!.;0WZA[MIU"7$,
MHM?'49EOAC,*K#CNB1^]UQ2P_8QZ^Z22.0LJAR-GLN+3;FE&QXF24\FB\"[)
MT"2+>H92I68EQ?CE6_9\H8-J,5TJ1CLS6XNL+4W$;O96Y?W+5Q/&)VW_K]2,
M&M^4YN7*\M1 T7@0/V2&)A\EQ%M:JL3SI4'90_=!!<A5M,0";)!0PS ?G7_S
M^G%'/)=3KK+"[JL>=K@?$SZQO57Q$J>32&;V%21B0_NY3Z&[WQCSAM3VF@:Q
M)''[^R''0RZK\0R$$TSH.>. 1[4K0H:-Y4 W"[S8AA=DC%G6^CUHD)VV_736
MN#H5QC B=HA?WC<.TR7C%8J<9I3%W0EJ1]@PD++BBY]KXR:(Q/!<V++J^ ?A
M.6I%@I;UAPG5)\TC/^IN"JAF>.X_I[L;^=:V/KU>?S8W,EM_X@NT]6<;@V/_
ML!,^S.5R?37=\=MX$@='&X]IJKU)$:#@IQ69'W+'[],\X=,\X=,\X8^<)SP$
MS0.D6:7>;*"9;\VLHP1-)C>>T*+PA.^ :; C^1)QR-)MKPEQV_#-N+W*XV0!
M*Z0/0D;!D#P+;3)K:U1Z/$WG%("@/MRCI?JF:6)29=ALA&4TD6]N#W SEG_>
MC&(]<?564NLCKK6[XDZ<]Z+(K%U(VE!\4>^=.RF=]EINJU5%[,R^SR71^^Y6
M[)Y]Q.1LLGEA@U+S[4LX-&->N_H2^U9KO;M9ZS9HNKINI38O6X'Z]R;MPE^)
M7E5T"%RV=3'JMYOGYSKEKR9-FO[F_;10D5RE45WK_;*">U)QTXT11=S6T4V;
M.9VN5OVWYFI,'/#<W$, 9>_8R+<BR'*H/9IJNB0C*+>HPL4W+PU_=R6F,[%C
MM]MPB8R<KJ33+3QVSQM^I=+VC?<LNO1;44+G_%6S8.C^>C+G;?8T+K?6)'KU
MO<?[9-K(*#(5I;1YV6HEM=#VXWL[]QO-]B6=]O<>:HBFXE9/S ]SNC(/*29^
M>JJI]1-N8X9C>4(3F@O<"U]3K:>ZN7?#)?/6]RPF.,PWZ;>O.5'IMESK<L?&
M-KLBM6U^<=?[!!"&F?0.M97H:QKLHC5/%%:M>+Y3M=5W;]W)?9_MX=@U ^NT
MUED::DW-2?_JYFI! S 4?M95=<(-!!89K,44A?(@YKO,H8AG-5,J_ LZ5JPO
M1,V"5*)#?. &7[@P[CGFL^Y35TN8S0V^22#8\Y1N&2%IJ'1<+/MJOU45OU-4
M*6KY@B<7*D#'ZOM+[7MLS+A:OQ+HO]S$?&[P\LYCS90TT5GI)-BR(W/WW]%P
M*LN4QQ:J^N'?RU]&P=;6;$],M9\RQ.A+IBHUP<]JIIA 2-0:1;3UNGX7M%#8
MY-[-K"90@[\DE9XJ6N:[O4HLPI=J?(KQ"AN)Y]Q:L"'I"!:X!>0\\H389V"E
MF+<N\G&P>*U@0KX7_ 6"_@2Q/T$I.N>-8FOL44B.7E]=A-3H<:?59>8X4!0D
MTE>*[]SAG>?4<!D.NO^D@\')<S6M:NJOC([#MXGX/F81ZM](77/K,O !5;Y1
M+:)!0L!\G;,CTO][XFMRC@#Y+.3.IH2;7LG,2ZTCEJ:.8S=*61#Q$DHWTIJZ
M=)GVEO_N.-+9M!Z?H.',@@PR"]]B(%K#-;EW[\@C3SWC%EH[MYLJ  QQT^1X
ML2O'OM_;RZ^DQ?[.!35'$F=/FW8.E0Y\XI<'5!S1E^J9J5@<^B*+;\>75IW&
M']J4'^',4 )2R4%P!A&NUUR^JFM77-OUDZOP7]H40.MC,U]3AC<.#WM'P\_;
MU5/8.U92'UR*/4"VS[]])5Z\_-?5ZYMO7[U>";;OTAWLT!30\S+JC9[N"RN^
M9[G]YX.9&@][3Y[\IESM:-]L,?:^M?1?3V-K7C4\V2/&R*NNKRY?G&]X5)]1
M8H^0XK_9$/] WCXAR)^*M]\92'XK_O8.71Z F-<2VXJKGKB0!;+K_4M$_JO1
MY &*NEAH64GQJK;6?-+2'N<@-ZAQKV5F"O7GS4$.GEWRC?!3,1Z?=$^>#KI/
MGXR//@6M/<HV5BHZ&C[MC@='W9/A^.DG%>U77G&?(STYWO\,8B=+UP8:4M[P
MCHX'W9/#)Z-/AK=7V-!64<0&\4E'^P8.04V$#:/1N'O\Y'#X)\>&O)=P(?&_
M]]Q?;+]X[U^9&5RG-S[Q)WVRUWW"E*174?%QGV;_VAK:)T1QO9QKCYU:8DCI
M\\@F7@;;OVMH?^&KD!]Z[_'6Z/1=UQ[[_B^\YK]!^]G_ U!+ 0(4 Q0    (
M %DZPUAG>'#_H0,  %\-   1              "  0    !Q=7)E+3(P,C0P
M-C S+GAS9%!+ 0(4 Q0    ( %DZPUB8JJL[8 4  +H[   5
M  "  = #  !Q=7)E+3(P,C0P-C S7VQA8BYX;6Q02P$"% ,4    " !9.L-8
M[3O03H\$   A)P  %0              @ %C"0  <75R92TR,#(T,#8P,U]P
M<F4N>&UL4$L! A0#%     @ 63K#6'!2E-&%%   ?H<  !0
M ( !)0X  '%U<F4M,C R-# V,#-X.&LN:'1M4$L! A0#%     @ 63K#6,F-
MXF_H$P  %5P  !@              ( !W"(  '%U<F4M,C R-# V,#-X97@Y
=.60Q+FAT;5!+!08     !0 % $T!  #Z-@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>qure-20240603x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="qure-20240603.xsd" xlink:type="simple"/>
    <context id="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001590560</identifier>
        </entity>
        <period>
            <startDate>2024-06-03</startDate>
            <endDate>2024-06-03</endDate>
        </period>
    </context>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Hidden_YkCjrdxncU2dd2-9nog91A">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Tc_dJHS-MCsAU-wGB5Fmk37DA_3_1">0001590560</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Tc_21EXZaubJkuYwE4eMwpt8A_4_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_md5reVqNQEGlN7zyH3gz3A">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_hEcUCgAnm0myVwWGIrSjQA">2024-06-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_Qd9mlma1eUOra0pUfFwcCw">uniQure N.V.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_6B5MhsO92ES1IslqrsQjOQ">P7</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Tc_OpsnB6cyZEiZSj07UU6M7w_1_2">001-36294</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_bPf8SnuMEkmPPbFNjqFTFQ">Paasheuvelweg 25a</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_ZQi4-KZdKk-jLyHqyrZw_A">1105 BP</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_8GsNLhI2qkur-2K_klUfAw">Amsterdam</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_zIm7XHBd_0OCjvu7uBNklw">NL</dei:EntityAddressCountry>
    <dei:CityAreaCode
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_yXn-4FiQTk-1wo9EZiK_Dw">+31</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_zsQIVp5ViEi09XeQ1EK0Kg">20-566-7394</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_Wprl41icdUetLrXXGgi3Kg">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_xjMZQM6QX0Cujji0gui8GA">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_JXlAwxFmkUiYC7pg5sqN0w">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_O5KB_10IU06Dth0vWWcdzA">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Tc_HVmhjzFxKkeg0AkqvbNF9A_2_0">Ordinary Shares, par value &#x20ac;0.05 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Tc_q5_p0WlZZUS-gQ3wY1CL0A_2_2">QURE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_ojse6a-Lc0-9AuVJUj1wvg">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_6_3_2024_To_6_3_2024_VyrXOAdtyk6L1wLZ3CARXA"
      id="Narr_8ZqHfpCvZEa9Gug2FtSUXA">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
